A new device for measurement of fibrin clot lysis: Application to the Euglobulin Clot Lysis Time

被引:27
|
作者
Zouaoui Boudjeltia K. [1 ]
Cauchie Ph. [1 ]
Remacle Cl. [3 ]
Guillaume M. [2 ]
Brohée D. [1 ]
Hubert J.L. [4 ]
Vanhaeverbeek M. [1 ]
机构
[1] Laboratoire Medecine Experimentale, Universite de Libre de Bruxelles, Hôpital A. Vésale, Montigny-le-Tilleul
[2] Departement de Cardiologie, Montigny-le-Tilleul
[3] Laboratoire de Biologie Cellulaire, Univ. Catholique de Louvain-La-Neuve, Louvain-La-Nueve
[4] EREM SA Company, Marcinelle
关键词
Efficiency Score; Fibrinogen Level; Venous Occlusion; Clot Lysis; Lysis Time;
D O I
10.1186/1472-6750-2-8
中图分类号
学科分类号
摘要
Background: Determination of clot lysis times on whole blood, diluted whole blood, plasma or plasma fraction has been used for many years to assess the overall activity of the fibrinolytic system. We designed a completely computerised semi-automatic 8-channel device for measurement and determination of fibrin clot lysis. The lysis time is evaluated by a mathematical analysis of the lysis curve and the results are expressed in minute (range: 5 to 9999). We have used this new device for Euglobulin Clot Lysis Time (ECLT) determination, which is the most common test used in laboratories to estimate plasma fibrinolytic capacity. Results: The correlation between ECLT and manual method is very tight : R = 0,99; p < 10-6. The efficiency scores of the method are <4% in intra-assay and <7% in inter-assay. It allows to achieve the tests on hyperlipaemic samples. This new device has been easily integrated in laboratory routine and allows to achieve several ECLT every day without disturbance of laboratory workflow. Conclusions: The routine use of this new device could be useful in various situations such as assessment in atherosclerosis and arteriosclerosis associated diseases, coagulation survey of liver transplantations, cardiovascular surgery or pharmacological research. It has already provided highly promising results in preliminary studies on the relation between fibrinolysis and cardiovascular risk factors. © 2002 Boudjeltia et al; licensee BioMed Central Ltd.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] EFFECTS OF CHRONIC ASPIRIN DOSING ON FIBRIN AGGREGATION AND CLOT LYSIS
    BJORNSSON, TD
    BERGER, H
    [J]. CLINICAL RESEARCH, 1984, 32 (02): : A238 - A238
  • [42] EFFECTS OF EPSILON-AMINOCAPROIC ACID ON FIBRIN CLOT LYSIS
    EGEBLAD, K
    [J]. THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1966, 15 (1-2): : 173 - &
  • [43] Reduced fibrin clot lysis in Klinefelter syndrome associated with hypogonadism
    Chang, Simon
    Goszczak, Arkadiusz J.
    Skakkebaek, Anne
    Fedder, Jens
    Bojesen, Anders
    Bor, M. Vakur
    de Maat, Moniek P. M.
    Gravholt, Claus H.
    Muenster, Anna-Marie B.
    [J]. ENDOCRINE CONNECTIONS, 2022, 11 (05)
  • [44] PAI-1 regulates fibrin clot stability and lysis
    Dassi, C.
    Fontaine, S.
    Mathieu, O.
    Seyve, L.
    Marlu, R.
    Polack, B.
    Caton, F.
    Contant, G.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 342 - 342
  • [45] EFFECTS OF SOY BEAN TRYPSIN INHIBITOR ON FIBRIN CLOT LYSIS
    EGEBLAD, K
    [J]. THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1966, 15 (3-4): : 542 - &
  • [46] Inhibition of fibrin clot and thrombus lysis by alpha(2)-antiplasmin
    Robbie, LA
    Keyt, B
    Bennett, B
    Booth, NA
    [J]. THROMBOSIS AND HAEMOSTASIS, 1997, : P1466 - P1466
  • [47] Weight Reduction Is Associated With Increased Plasma Fibrin Clot Lysis
    Brzezinska-Kolarz, Beata
    Kolarz, Marek
    Walach, Angelika
    Undas, Anetta
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2014, 20 (08) : 832 - 837
  • [48] CAPILLARY INDICATOR IN DETERMINATION OF CLOT LYSIS TIME
    KONTTINEN, Y
    KOSKINEN, EH
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1961, 13 (04): : 694 - &
  • [49] EFFECTIVENESS OF ACTIVATORS IN CLOT LYSIS, WITH SPECIAL REFERENCE TO FIBRINOLYTIC THERAPY - A NEW METHOD FOR DETERMINATION OF PREFORMED CLOT LYSIS
    BLIX, S
    [J]. ACTA MEDICA SCANDINAVICA, 1962, 172 : 1 - +
  • [50] Prolonged euglobulin clot lysis time does not always indicate impaired fibrinolysis in chronic hemodialysis patients
    Rydzewska-Rosolowska, A
    Borawski, J
    Naumnik, B
    Mysliewiec, M
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V320 - V320